Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

623 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HIV-infected individuals with the CCR delta32/CCR5 genotype have lower HIV RNA levels and higher CD4 cell counts in the early years of the infection than do patients with the wild type. Copenhagen AIDS Cohort Study Group.
Katzenstein TL, Eugen-Olsen J, Hofmann B, Benfield T, Pedersen C, Iversen AK, Sørensen AM, Garred P, Koppelhus U, Svejgaard A, Gerstoft J. Katzenstein TL, et al. Among authors: gerstoft j. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Sep 1;16(1):10-4. doi: 10.1097/00042560-199709010-00002. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9377119
Granulocyte colony-stimulating factor increases CD4+ T cell counts of human immunodeficiency virus-infected patients receiving stable, highly active antiretroviral therapy: results from a randomized, placebo-controlled trial.
Aladdin H, Ullum H, Dam Nielsen S, Espersen C, Mathiesen L, Katzenstein TL, Gerstoft J, Skinhoj P, Pedersen BK. Aladdin H, et al. Among authors: gerstoft j. J Infect Dis. 2000 Mar;181(3):1148-52. doi: 10.1086/315305. J Infect Dis. 2000. PMID: 10720544 Clinical Trial.
The danish protease inhibitor study: a randomized study comparing the virological efficacy of 3 protease inhibitor-containing regimens for the treatment of human immunodeficiency virus type 1 infection.
Katzenstein TL, Kirk O, Pedersen C, Lundgren JD, Nielsen H, Obel N, Nielsen C, Mathiesen LR, Gerstoft J. Katzenstein TL, et al. Among authors: gerstoft j. J Infect Dis. 2000 Sep;182(3):744-50. doi: 10.1086/315746. Epub 2000 Aug 3. J Infect Dis. 2000. PMID: 10950767 Clinical Trial.
623 results